These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

735 related items for PubMed ID: 17296941

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting.
    Lobov IB, Renard RA, Papadopoulos N, Gale NW, Thurston G, Yancopoulos GD, Wiegand SJ.
    Proc Natl Acad Sci U S A; 2007 Feb 27; 104(9):3219-24. PubMed ID: 17296940
    [Abstract] [Full Text] [Related]

  • 5. Extrinsic Notch ligand Delta-like 1 regulates tip cell selection and vascular branching morphogenesis.
    Napp LC, Augustynik M, Paesler F, Krishnasamy K, Woiterski J, Limbourg A, Bauersachs J, Drexler H, Le Noble F, Limbourg FP.
    Circ Res; 2012 Feb 17; 110(4):530-5. PubMed ID: 22282195
    [Abstract] [Full Text] [Related]

  • 6. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis.
    Adam MG, Berger C, Feldner A, Yang WJ, Wüstehube-Lausch J, Herberich SE, Pinder M, Gesierich S, Hammes HP, Augustin HG, Fischer A.
    Circ Res; 2013 Nov 08; 113(11):1206-18. PubMed ID: 24025447
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
    Li JL, Sainson RC, Oon CE, Turley H, Leek R, Sheldon H, Bridges E, Shi W, Snell C, Bowden ET, Wu H, Chowdhury PS, Russell AJ, Montgomery CP, Poulsom R, Harris AL.
    Cancer Res; 2011 Sep 15; 71(18):6073-83. PubMed ID: 21803743
    [Abstract] [Full Text] [Related]

  • 9. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.
    Li JL, Sainson RC, Shi W, Leek R, Harrington LS, Preusser M, Biswas S, Turley H, Heikamp E, Hainfellner JA, Harris AL.
    Cancer Res; 2007 Dec 01; 67(23):11244-53. PubMed ID: 18056450
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions.
    Hainaud P, Contrerès JO, Villemain A, Liu LX, Plouët J, Tobelem G, Dupuy E.
    Cancer Res; 2006 Sep 01; 66(17):8501-10. PubMed ID: 16951162
    [Abstract] [Full Text] [Related]

  • 12. Nrf2 acts cell-autonomously in endothelium to regulate tip cell formation and vascular branching.
    Wei Y, Gong J, Thimmulappa RK, Kosmider B, Biswal S, Duh EJ.
    Proc Natl Acad Sci U S A; 2013 Oct 08; 110(41):E3910-8. PubMed ID: 24062466
    [Abstract] [Full Text] [Related]

  • 13. ADAM10 and ADAM17 have opposite roles during sprouting angiogenesis.
    Caolo V, Swennen G, Chalaris A, Wagenaar A, Verbruggen S, Rose-John S, Molin DG, Vooijs M, Post MJ.
    Angiogenesis; 2015 Jan 08; 18(1):13-22. PubMed ID: 25218057
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Feed-forward signaling by membrane-bound ligand receptor circuit: the case of NOTCH DELTA-like 4 ligand in endothelial cells.
    Caolo V, van den Akker NM, Verbruggen S, Donners MM, Swennen G, Schulten H, Waltenberger J, Post MJ, Molin DG.
    J Biol Chem; 2010 Dec 24; 285(52):40681-9. PubMed ID: 20959466
    [Abstract] [Full Text] [Related]

  • 19. Dll4-Notch1 signaling but not VEGF-A is essential for hyperoxia induced vessel regression in retina.
    Zhu G, Lin Y, Liu H, Jiang D, Singh S, Li X, Yu Z, Fan L, Wang S, Rhen J, Li W, Xu Y, Ge J, Pang J.
    Biochem Biophys Res Commun; 2018 Dec 09; 507(1-4):400-406. PubMed ID: 30448061
    [Abstract] [Full Text] [Related]

  • 20. Dosage-sensitive requirement for mouse Dll4 in artery development.
    Duarte A, Hirashima M, Benedito R, Trindade A, Diniz P, Bekman E, Costa L, Henrique D, Rossant J.
    Genes Dev; 2004 Oct 15; 18(20):2474-8. PubMed ID: 15466159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.